None, one, or two-plus affected first-degree relatives—often a starting point for genetic counseling and MRI eligibility discussions.

Pathogenic variants trigger a dedicated high-risk pathway in this tool; negative or unknown results continue through the general checklist.

High-risk benign pathology and some reproductive timing patterns are weighted in many educational models—always confirm pathology reports with your clinician.

Broad age groups align with when mammography and supplemental screening conversations are common—not a substitute for national screening program rules.

If you report invasive breast cancer or DCIS, the tool defers to specialist follow-up rather than a primary-prevention score.

Male breast cancer is uncommon; the checklist explains limits and when to seek care for symptoms or known mutations.